| Literature DB >> 21224923 |
Roshan S Livingstone1, B S Timothy Peace, Sunil Chandy, Paul V George, Purendra Pati.
Abstract
The percutaneous transluminal coronary angioplasty (PTCA) is one of the interventional procedures which impart high radiation doses to patients compared to the other cardiologic procedures. This study intends to audit and optimize radiation dose imparted to patients undergoing PTCA. Forty-four patients who underwent PTCA involving single or multiple stent placement guided under cardiovascular X-ray machine were included in the study. Radiation doses were measured using dose area product (DAP) meter for patients undergoing single and multiple stent placements during PTCA. A dose reduction of 27-47% was achieved using copper filters and optimal exposure parameters. The mean DAP values before optimization were 66.16 and 122.68 Gy cm(2) for single and multiple stent placement respectively. These values were 48.67 and 65.44 Gy cm(2) respectively after optimization. In the present scenario, due to the increase in the number of PTCAs performed and the associated risk from radiation, periodical audit of radiation doses for interventional procedures are recommended.Entities:
Keywords: Dose area product; radiation dose
Year: 2007 PMID: 21224923 PMCID: PMC3014098 DOI: 10.4103/0971-6203.37478
Source DB: PubMed Journal: J Med Phys ISSN: 0971-6203
Figure 1Diamentor - dose area product meter fitted on top of the collimator assembly
Patient-related and exposure parameters during percutaneous transluminal coronary angioplasty
| P2 | Single stent | 15 | 57 | 163 | 64 | 85 | 21 | 75 | 622 | 14.4 (7−23) | 1283 (570−2204) | 10.99 (4.9−26.5) |
| Multiple stent | 6 | 59 | 167 | 66 | 93 | 20 | 75 | 667 | 23 (17−28) | 2107 (1310−2605) | 17.62 (11.1−25.8) | |
| Single stent | 18 | 50 | 164 | 64 | 105 | 6 | 79 | 723 | 17.2 (8−31) | 1566 (689−3367) | 11.57 (5−29.9) | |
| Multiple stent | 5 | 53 | 166 | 71 | 107 | 6 | 81 | 740 | 20.8 (17−27) | 1761 (1218−2522) | 17.72 (7.9−24.8) | |
- optimized values in Philips Integris 5000 machine.
Dose area product values for percutaneous transluminal coronary angioplasty before and after optimization
| P2 | Single stent | 26.13 ± 15.9 (10.7-75) | 39.87 ± 20.87 (12.9-87.9) | 66.16 ± 31.3 (28.2-113.6) | 40.34 (14.5-56.46) | 31.57 (17.11-45.92) |
| Multiple stent | 47.72 ± 23.32 (24.4-75.5) | 74.97 ± 34.25 (36-102.6) | 122.68 ± 55.75 (60.4-160.8) | 44.89 (35.36-55.43) | 35.71 (22.77-46.7) | |
| Single stent | 17.88 ± 9.55 (6.9-39.2) | 30.79 ± 16.9 (9-66.2) | 48.67 ± 24.95 (21.3-98.1) | 25.38 (14.02-41.88) | 19.3 (10.21-28.7) | |
| Multiple stent | 31.42 ± 21.46 (8.7-57.8) | 34.02 ± 20.43 (13.6-52.4) | 65.44 ± 42.78 (22.3-109.5) | 26.82 (18.19-39.16) | 18.27 (10.91-23.89) | |
- optimized values.
DAP values for PTCA in comparison with those from studies in literature
| Vano | 87.5 |
| Betsou | 38 |
| Broad head | 72.2 |
| Efstathopoulos | 75 |
| Van der Putte | 108 |
| Tsapaki[ | 68 |
| NRPB[ | 63 |
| Kuon | 14.4 |
| Current study | 48.67 |
| Current study | 65.44 |
- optimized values.